These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34945830)

  • 1. Adjuvant Whole Breast Radiotherapy Improve Survival in Women with Heart Failure with Reduced Ejection Fraction Receiving Breast-Conserving Surgery.
    Zhang J; Sum SY; Hsu JG; Chiang MF; Lee TS; Wu SY
    J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant Radiotherapy Is Associated with an Increase in the Survival of Old (Aged over 80 Years) and Very Old (Aged over 90 Years) Women with Breast Cancer Receiving Breast-Conserving Surgery.
    Huang CC; Chang CL; Sun M; Chiang MF; Sum SY; Zhang J; Wu SY
    J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant postmastectomy radiotherapy might be associated with better survival in women with heart failure receiving total mastectomy.
    Zhang J; Sum SY; Hsu JG; Chiang MF; Lee TS; Wu SY
    Radiat Oncol; 2022 Feb; 17(1):33. PubMed ID: 35151355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast-conserving surgery with or without irradiation in women with invasive ductal carcinoma of the breast receiving preoperative systemic therapy: A cohort study.
    Zhang J; Lu CY; Qin L; Chen HM; Wu SY
    Breast; 2020 Dec; 54():139-147. PubMed ID: 33049657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic response rates for breast cancer stages as a predictor of outcomes in patients receiving neoadjuvant chemotherapy followed by breast-conserving surgery.
    Zhang J; Lu CY; Chen HM; Wu SY
    Surg Oncol; 2021 Mar; 36():91-98. PubMed ID: 33316685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term oncologic outcomes of breast conserving surgery with propofol-based total intravenous anesthesia or volatile inhalational general anesthesia without propofol: a propensity score-matched, population-based cohort study.
    Zhang J; Chang CL; Lu CY; Chen HM; Wu SY
    Am J Cancer Res; 2021; 11(10):4966-4980. PubMed ID: 34765304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paravertebral block in regional anesthesia with propofol sedation reduces locoregional recurrence in patients with breast cancer receiving breast conservative surgery compared with volatile inhalational without propofol in general anesthesia.
    Zhang J; Chang CL; Lu CY; Chen HM; Wu SY
    Biomed Pharmacother; 2021 Oct; 142():111991. PubMed ID: 34449311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
    van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
    Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anesthesia With Propofol Sedation Reduces Locoregional Recurrence in Patients With Breast Cancer Receiving Total Mastectomy Compared With Non-Propofol Anesthesia.
    Zhang J; Chang CL; Lu CY; Chen HM; Wu SY
    Front Oncol; 2022; 12():708632. PubMed ID: 35311108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic response as predictor of recurrence, metastasis, and survival in breast cancer patients receiving neoadjuvant chemotherapy and total mastectomy.
    Zhang J; Sun M; Chang E; Lu CY; Chen HM; Wu SY
    Am J Cancer Res; 2020; 10(10):3415-3427. PubMed ID: 33163280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ.
    Williamson D; Dinniwell R; Fung S; Pintilie M; Done SJ; Fyles AW
    Radiother Oncol; 2010 Jun; 95(3):317-20. PubMed ID: 20400190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
    Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcomes of adjuvant whole-brain radiotherapy versus hypofractionated stereotactic radiotherapy after surgical resection of brain metastases: a propensity score-matched analysis.
    Keller A; Lefebvre F; Ricard D; Noël G; Antoni D
    Chin Clin Oncol; 2020 Aug; 9(4):55. PubMed ID: 32576020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overall survival according to type of surgery in young (≤40 years) early breast cancer patients: A systematic meta-analysis comparing breast-conserving surgery versus mastectomy.
    Vila J; Gandini S; Gentilini O
    Breast; 2015 Jun; 24(3):175-81. PubMed ID: 25728282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of Chemotherapy and Radiotherapy Following Breast-Conserving Surgery for Early-Stage Breast Cancer: A Retrospective Analysis.
    Chen SY; Tang Y; Wang SL; Song YW; Fang H; Wang JY; Jing H; Zhang JH; Sun GY; Zhao XR; Jin J; Liu YP; Chen B; Qi SN; Li N; Tang Y; Lu NN; Ren H; Yu ZH; Li YX
    Front Oncol; 2020; 10():571390. PubMed ID: 33072604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for locoregional recurrence and survival in stage IIIC breast carcinoma: impact of adjuvant radiotherapy.
    Kuru B
    Singapore Med J; 2011 Apr; 52(4):289-98. PubMed ID: 21552792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involved margins after lumpectomy for breast cancer: Always to be re-excised?
    Sorrentino L; Agozzino M; Albasini S; Bossi D; Mazzucchelli S; Vanna R; Papadopoulou O; Villani L; Corsi F
    Surg Oncol; 2019 Sep; 30():141-146. PubMed ID: 31500779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
    El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
    Front Oncol; 2020; 10():693. PubMed ID: 32477942
    [No Abstract]   [Full Text] [Related]  

  • 19. Survival benefit of anti-HER2 therapy after whole-brain radiotherapy in HER2-positive breast cancer patients with brain metastasis.
    Zhang Q; Chen J; Yu X; Cai G; Yang Z; Cao L; Hu C; Guo X; Sun J; Chen J
    Breast Cancer; 2016 Sep; 23(5):732-9. PubMed ID: 26267412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
    Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.